产品描述信息
HM-991??Staphylococcus aureus, CM05(Bacteria)|Staphylococcus aureus|CM05|-60°C or colder|CA AriasAcknowledgment for publications should read "The following reagent was obtained through BEI Resources, NIAID, NIH as part of the Human Microbiome Project: Staphylococcus aureus, Strain CM05, HM-991."|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.
Staphylococcus aureus (S. aureus), strain CM05 was isolated in 2005 in Medellin, Colombia
from a tracheal aspirate of a patient with a fatal ventilator-associated pneumonia.
S. aureus, strain CM05 (
HMP ID 1384) is a linezolid-resistant S. aureus (LRSA), methicillin-resistant S. aureus (MRSA) strain. Strain CM05 exhibited resistance to linezolid as well as to several other antibiotics. The patient received only two doses of linezolid, and thus, the emergence of linezolid resistance was rather unexpected and had been previously associated with prolonged treatment with the antibiotic. In addition to linezolid, strain CM05 is reported to be resistant to chloramphenicol,
ciprofloxacin, clindamycin, dalfopristin, erythromycin, gentamicin, oxacillin and quinupristin; it shows sensitivity to rifampin, teicoplanin, tetracycline and vancomycin. S. aureus, strain CM05 is a reference genome for
The Human Microbiome Project (HMP). HMP is an initiative to
identify and characterize human microbial flora. The complete genome of S. aureus, strain CM05
was sequenced by the Genome Institute at
Washington University (GenBank:
AMAB00000000).
Each vial contains approximately 0.5 mL of bacterial culture in Tryptic Soy broth supplemented with 10% glycerol.